Go to main content
Tillbaka till Back to kd-ventures.com
SV EN

Nomination Committee

The Nomination Committee for the 2026 Annual General Meeting consists of:

  • Jack Li, appointed by invoX Pharma Ltd
  • Anders Hallberg, appointed by Anders Hallberg
  • Jan Dworsky, appointed by the Swedbank Robur Microcap fund
  • Hans Wigzell, appointed by the Fundraising Foundation for the Promotion and Development of Medical Research at KI
  • Peter Markborn, appointed by Styviken Invest AS

Proposals to the Nomination Committee may be sent to the company's General Counsel, Johan Dighed, johan.dighed@kd-ventures.com, no later than 4 March 2026.

In connection with the rights issue carried out in January 2026, Yan Cheng (appointed by Worldwide International Investments Ltd) left the Nomination Committee and was replaced by Anders Hallberg.

Cookies

This website uses cookiesfor statistics and user experience.

The website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website, and to offer more relevant offers to you.

Please read our privacy policy. If you consent to our use, select Allow all. If you want to change your choice later, you can find that option at the bottom of the page.